First Time Loading...

Zosano Pharma Corp
NASDAQ:ZSAN

Watchlist Manager
Zosano Pharma Corp Logo
Zosano Pharma Corp
NASDAQ:ZSAN
Watchlist
Price: 1 USD -43.18% Market Closed
Updated: May 6, 2024

Zosano Pharma Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zosano Pharma Corp
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Zosano Pharma Corp
NASDAQ:ZSAN
Operating Income
-$30.9m
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.5B
CAGR 3-Years
46%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.5B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is Zosano Pharma Corp's Operating Income?
Operating Income
-30.9m USD

Based on the financial report for Mar 31, 2022, Zosano Pharma Corp's Operating Income amounts to -30.9m USD.

What is Zosano Pharma Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-2%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Zosano Pharma Corp have been 6% over the past three years , -2% over the past five years .